Unnatural Amino Acid Incorporation onto Adenoviral (Ad) Coat Proteins Facilitates Chemoselective Modification and Retargeting of Ad Type 5 Vectors

被引:27
作者
Banerjee, Partha Sarathi [1 ,2 ]
Ostapchuk, Philomena [3 ]
Hearing, Patrick [3 ]
Carrico, Isaac Sheridan [1 ,2 ]
机构
[1] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA
基金
美国国家科学基金会;
关键词
GENE DELIVERY; CRYOELECTRON MICROSCOPY; RECOMBINANT ADENOVIRUS; FIBER; RESOLUTION; TERMINUS; LIGANDS; TROPISM;
D O I
10.1128/JVI.00118-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Surface modification of adenovirus vectors can improve tissue-selective targeting, attenuate immunogenicity, and enable imaging of particle biodistribution, thus significantly improving therapeutic potential. Currently, surface engineering is constrained by a combination of factors, including impact on viral fitness, limited access to functionality, or incomplete control over the site of modification. Here, we report a two-step labeling process involving an initial metabolic placement of a uniquely reactive unnatural amino acid, azidohomoalanine (Aha), followed by highly specific chemical modification. As genetic modification of adenovirus is unnecessary, vector production is exceedingly straightforward. Aha incorporation demonstrated no discernible impact on either virus production or infectivity of the resultant particles. "Click" chemical modification of surface-exposed azides was highly selective, allowing for the attachment of a wide range of functionality. Decoration of human adenovirus type 5 (hAd5) with folate, a known cancer-targeting moiety, provided an similar to 20-fold increase in infection of murine breast cancer cells (4T1) in a folate receptor-dependent manner. This study demonstrates that incorporation of unnatural amino acids can provide a flexible, straightforward route for the selective chemical modification of adenoviral vectors.
引用
收藏
页码:7546 / 7554
页数:9
相关论文
共 37 条
  • [1] Replicative adenoviruses for cancer therapy
    Alemany, R
    Balagué, C
    Curiel, DT
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (07) : 723 - 727
  • [2] Alemany Ramon, 2009, V542, P57, DOI 10.1007/978-1-59745-561-9_2
  • [3] Chemoselective Attachment of Small Molecule Effector Functionality to Human Adenoviruses Facilitates Gene Delivery to Cancer Cells
    Banerjee, Partha Sarathi
    Ostapchuk, Philomena
    Hearing, Patrick
    Carrico, Isaac
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (39) : 13615 - 13617
  • [4] Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein
    Belousova, N
    Krendelchtchikova, V
    Curiel, DT
    Krasnykh, V
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (17) : 8621 - 8631
  • [5] Stabilization of recombinant adenovirus: Site-directed mutagenesis of key asparagine residues in the hexon protein
    Blanche, F
    Cameron, B
    Somarriba, S
    Maton, L
    Barbot, A
    Guillemin, T
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 297 (01) : 1 - 9
  • [6] Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector
    Campos, SK
    Parrott, MB
    Barry, MA
    [J]. MOLECULAR THERAPY, 2004, 9 (06) : 942 - 954
  • [7] Targeted gene delivery by tropism-modified adenoviral vectors
    Douglas, JT
    Rogers, BE
    Rosenfeld, ME
    Michael, SI
    Feng, MZ
    Curiel, DT
    [J]. NATURE BIOTECHNOLOGY, 1996, 14 (11) : 1574 - 1578
  • [8] The C-Terminal Domains of Adenovirus Serotype 5 Protein IX Assemble into an Antiparallel Structure on the Facets of the Capsid
    Fabry, Celine M. S.
    Rosa-Calatrava, Manuel
    Moriscot, Christine
    Ruigrok, Rob W. H.
    Boulanger, Pierre
    Schoehn, Guy
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (02) : 1135 - 1139
  • [9] A quasi-atomic model of human adenovirus type 5 capsid
    Fabry, CMS
    Rosa-Calatrava, M
    Conway, JF
    Zubieta, C
    Cusack, S
    Ruigrok, RWH
    Schoehn, G
    [J]. EMBO JOURNAL, 2005, 24 (09) : 1645 - 1654
  • [10] Transductional targeting of adenovirus vectors for gene therapy
    Glasgow, J. N.
    Everts, M.
    Curiel, D. T.
    [J]. CANCER GENE THERAPY, 2006, 13 (09) : 830 - 844